| 영문 | vaccination | 한글 | 예방접종 |
|---|---|---|---|
| 설명 | 1.인위적으로 능동면역을 성립시켜서 감염에 대한 저항력을 높이기 위하여 약독화병원체(생백신) 또는 사균, 불활성 화백신 등을 접종하는 것을 말한다. 당초 종두는 젠너(Jenner)에 의해서 발견된 마마 예방법에 관한 접종을 의미했으나 현재에는 널리 감염증이나 전염병의 병원균 그 자체가 일부를 접종해서 비감염자를 면역하는 것을 의미한다. 예방접종으로 표준화되었으며, 항원으로서 백신이 사용된다. 예방접종으로 감염이 억제되지만 피부에 나타나는 이상이나 두드러기모양 홍반 등의 피부발진이나 뇌염 등의 부작용이 나타날 수 있으므로 주의를 요한다. 2.예방접종에 쓰이는 항원에는 크게 나누어 세균성 항원과 바이러스성 항원이 있는데, 세균성 항원에는 사멸된 전체 세균(백일해 백신 등), 병원체가 체외로 배출하는 독소를 멸독한 변성독소(톡소이드)(디프테리아-파상풍 등), 독력을 약화시킨 생세균체(BCG 등)등이 있고, 바이러스성 항원에는 생약독화한 것(소아마비)과 사멸된 백신(인플루엔자) 등이 포함된다. 한국에서는 전염병 예방법에 두창-디프테리아-백일해-장티푸스-콜레라-파상풍-결핵 등 일곱 개 질병에 관하여 정기 예방접종을 시행하도록 되어 있다. 또 대한소아과학회에서는 BCG-소아마비-디프테리아-백일해-파상풍-홍역-유행성귀밑샘염(볼거리)-풍진-일본뇌염 등 아홉 개 예방접종을 정하고 있다. |
||
| 영문 | hyperthermia, fever | 한글 | 고열 |
|---|---|---|---|
| 설명 | 체온조절 중추가 이상을 초래해 체온이 계속 상승하여 지속되고 있는 상태를 말한다. 원인은 다양하며 체온조절 중추의 장애(뇌질환), 조직장애에 의한 것이 있다. 체온은 일반적으로 겨드랑이, 입안, 곧창자에서 재고, 시간은 10분을 필요로 한다. 통상 37℃ 이하(겨드랑이)로, 입안 온도는 이보다 0.1~0.2℃ 높으며, 곧창자온도는 0.2~0.5℃ 높다. 고체온증에서도 동결과 유사한 세포 변화가 나타난다. 즉 혈관내피세포에 손상이 생기고 혈관투과가 증가되어 부종, 수포 등이 형성된다. |
||
| 영문 | dengue fever | 한글 | 뎅기 |
|---|---|---|---|
| 설명 | 주로 열대지방에서 발생하는 바이러스성 열병. 4~8일의 잠복기를 거쳐 급격하게 발열하고, 결막충혈-관절통-근육통-백혈구감소 등의 증상을 보인다. 대부분 7~10일 후에는 회복되며, 사망하는 예는 드물다. 미국의 세균학자인 C.F. 크레이그는 1907년 필리핀에서 뎅기열은 모기에 의해 감염된다는 것을 확인-보고했다. 제2차 세계대전 직후 미국의 세균학자 A. B. 세이빈은 그의 연구에 의해 뎅기열 바이러스에는 면역학적으로 네가지 형이 있다고 밝혔다. 뎅기열 바이러스를 매개하는 모기에는 이집트숲모기(Aedes aegypti)와 흰줄숲모기(Aedes albopictus)가 알려져 있다. 이 병에 걸리고 나면 면역이 생기지만 지속기간은 비교적 짧다. |
||
| 영문 | typhus fever | 한글 | 발진티푸스 |
|---|---|---|---|
| 설명 | 고열과 발진이 주증세인 열성-급성의 법정전염병. 세계보건기구(WHO)의 보건규칙에 의한 국제 감시 전염병의 하나이기도 하다. 또한, 이 병의 유행은 전쟁과 관계가 깊어 전쟁티푸스 또는 기근열-교도소열 등의 별명이 있다. 그것은 이 병의 매개곤충인 ‘옷이’가 의류나 몸이 더러울 때 발생하기 쉬우므로 군대나 교도소, 전쟁터 등 환경이 나쁜 곳에서 크게 유행하게 되었기 때문이었다. 제1차 세계대전 당시 러시아에서 발생한 환자의 수는 2,500만 명이나 되었고, 영국과 기타 유럽에서도 전쟁-기근 때문에 이 병이 대유행했던 기록이 있으며, 일본에서도 제2차 세계대전 직후에 유행 했었다. 오늘날에는 아프리카-유럽-아시아의 일부지역에만 존재할 뿐이다. 병원체는 리케차 프로바제키(Rickettsia prowazeki)로 옷이에 기생증식하여 옷이의 분변과 함께 배설되면서 옷이가 흡혈하기 위해 피부에 준 상처나 사람이 손으로 긁어 생긴 상처를 통하여 감염된다. 잠복기간은 10~14일이며 급작스런 오한이나 함께 발열하여 3일 정도 경과되면 40℃ 전후의 고열이 나게 되고, 두통-관절통-결막충혈 등과 지름 2mm 안팎의 붉고 작은 출혈성 발진이 온몸에 많이 생긴다. 증세는 장티푸스와 비슷하고, 바일-펠릭스반응(Weil-Felix test)이라 하는 혈청반응에 의해 감별된다. 클로람페니콜이나 테트라사이클린계의 항생물질이 특효를 보여 치사율도 낮아졌다(20%). 예방으로는 살충제로 옷이를 구제하는 것이 가장 중요하며, 발진티푸스백신 접종도 유효하다. |
||
| 영문 | scarlet fever | 한글 | 성홍열 |
|---|---|---|---|
| 설명 | A형용혈사슬알균에 의한 법정 급성전염병이다. 5~10세의 소아에서 호발한다. 작은 침방울을 통하여 감염되며 잠복기인 2~4일을 지나, 초기증상은 고열, 인두점막, 편도가 현저하게 발적종대된다. 1~2일 후 비융합성의 홍색소구진이 전신에 출현한다. 입 언저리에는 발진이 없고 입술주위는 창백하며 딸기혀를 본다. 2~3일 후 발진이 사라진다. 병변부의 대부분은 표층이 박리되는데 특히 손과 발의 융합성 탈피가 특징이다. 현재는 과거에 비하여 훨씬 병이 가벼워져서 중이염, 바위, 화농림프절염도 드물다. 인두점막배양으로 균을 증명하여 진단한다. A군 사슬알균감염의 합병증으로는 면역복합체성콩팥염과 류마티스열이 된다. |
||
| HFRS | Hemorrhagic Fever with Renal Syndrome [HP 849-50] = Korean Hemorrhagic Fever &nbs... |
|---|---|
| vacc | vaccination |
| VS | vaccination scar; vaccine serotype; vagal stimulation; vasospasm; venesection; ventricular septum; v... |
| YF | yellow fever |
| YFI | yellow fever immunization |
| PV | post vaccination |
|---|---|
| YF | Yellow Fever |
| YF | Yellow Fever virus |
| YFV | Yellow Fever virus |
| BYDV | Barley yellow dwarf virus |
primary's area
| yellow fever vaccination | A live attenuated (weakened) viral vaccine recommended for people traveling to or living in tropical areas in the americas and africa where yellow fever occurs. (12 Dec 1998) |
|---|
| jungle yellow fever | A form occurring in South America, transmitted by Aedes leucocelaenus and various treetop mosquitoes of the Haemagogus complex; transmitted normally to primates, occasionally by chance to man to set off a human outbreak of classical yellow fever transmitted by Aedes aegypti. (05 Mar 2000) |
|---|---|
| yellow fever | <microbiology> An acute febrile illness of tropical regions, caused by a group B arbovirus and spread by a mosquito (Aedes aegypti). Characteristic features include: jaundice, black vomit and the absence of urination. Vaccination is available for travelers to endemic areas. (27 Sep 1997) |
| yellow fever vaccine | A living, attenuated strain (17D) of yellow fever virus propagated in embryonated fowl eggs. A suspension of dried mouse brain infected with French neurotropic (Dakar) strain of yellow fever virus, administered topically by the scratch method; not officially recommended in the United States because of meningoencephalitic reactions. (05 Mar 2000) |
| yellow fever virus | <virology> A togavirus (Class IV) with an RNA genome responsible for the disease of the name whose symptoms include fever and haemorrhage. Transmitted by the mosquitoes Aedes aegypti and Haemagogus. Only one antigenic type of the virus known and causes fatal hepatitis in many primates, including humans. This virus is endemic to areas of Africa, South America and the Carribean and has been a major epidemic threat. (11 May 1997) |
| vaccination | <procedure> The introduction of vaccine into the body for the purpose of inducing immunity. Coined originally to apply to the injection of smallpox vaccine, the term has come to mean any immunising procedure in which vaccine is injected. Origin: L. Vacca = cow (18 Nov 1997) |
| vaccination, anthrax | A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the usa was first developed in the 1950s and approved by the food and drug administration for general use in 1970. It is produced by the michigan biologic products institute of michigan's department of health and is given routinely to veterinarians and others working with livestock. In december, 1997 it was announced that all us military would receive the vaccine, as do the military in the uk and russia, the reason being concern that anthrax might be used in biologic warfare. (12 Dec 1998) |
| vaccination, chickenpox | This vaccine prevents the common disease known as chickenpox (varicella zoster). While chickenpox is often considered a trivial illness, it can cause significant lost time on the job and in school and have serious complications including ear infections, pneumonia, and infection of the rash with bacteria, inflammation of the brain (encephalitis) leading to difficulty with balance and coordination (cerebellar ataxia), damaged nerves (palsies), and reye's syndrome, a potentially fatal complication. The vaccination requires only one shot given at about a year of age. If an older person has not had chickenpox, the shot may be given at any time. There have been few significant reactions to the chickenpox vaccine. All children, except those with a compromised immune system, should have the vaccination. (12 Dec 1998) |
| vaccination, children's | In the United States, it is recommended that all children receive vaccination against: - hepatitis b - diphtheria, tetanus, pertussis - haemophilus influenzae type b (hib), poliovirus, measles, mumps, rubella, varicella zoster virus (chickenpox). Every child in the u.s. Should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination. (12 Dec 1998) |
| vaccination, dpt | DPT immunization protects from diphtheria, pertussis (whooping cough), and tetanus and is given in a series of 5 shots at 2, 4, 6, 18 months of age and 4-6 years of age. Thanks to vaccination programs, these diseases have become less common. However, there are still unvaccinated individuals capable of carrying and passing diphtheria and pertussis to others who are not vaccinated. Tetanus bacteria are prevalent in natural surroundings, such as contaminated soil. See also vaccination, dtap. (12 Dec 1998) |
| vaccination, dt | DT (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease (12 Dec 1998) |
| vaccination, dtap | Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age. (12 Dec 1998) |
| vaccination, german measles | See Vaccination, MMR. (12 Dec 1998) |
| vaccination, haemophilus influenzae type b | See vaccination, hib. (12 Dec 1998) |
| vaccination, hepatitis a | When immediate protection against hepatitis a (infectious hepatitis) is needed, immunoglobulins are used. Protection is effective only if given within 2 weeks of exposure and lasts but 2-4 months. Immunoglobulins can be used to protect household contacts of someone with acute viral hepatitis and travelers to regions with poor sanitation and high hepatitis a rates, when the traveler has to depart sooner than the vaccines can take effect (about 2 weeks). Travelers can receive the immunoglobulin and vaccine simultaneously and be protected immediately and for longer term. When immediate protection is not needed, hepatitis a vaccines are considered for individuals in high-risk settings, including frequent world travelers, sexually active individuals with multiple partners, homosexual men, individuals using illicit drugs, employees of daycare centres, and certain health care workers, and sewage workers. Two hepatitis a vaccines called havrix and vaqta are commercially available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. (12 Dec 1998) |
| vaccination, hepatitis b | Hepatits B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. Vaccination, hepatitis b: hepatits b (hep b) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are usually given both hbig and vaccine to provide immediate and long term protection. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|